Skip to main content
Ceapro Inc. logo

Ceapro Inc. — Investor Relations & Filings

Ticker · CZO ISIN · CA1499071076 TSXV Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2024-06-08 Regulatory Filings
Country CA Canada
Listing TSXV CZO

About Ceapro Inc.

www.ceapro.com

Ceapro Inc. is a biotechnology company specializing in the development and commercialization of natural-based active ingredients derived primarily from oats and other renewable sources. The company utilizes proprietary extraction technology to produce high-value compounds, including Oat Beta Glucan, Oat Avenanthramides, and Oat Oil. These ingredients are engineered for applications across multiple sectors. Key markets include cosmeceuticals (for skin barrier function, hydration, and anti-aging), nutraceuticals (for cholesterol management and gut health), and pharmaceuticals (currently developing anti-inflammatory treatments). The company's unique focus is on combining the simplicity of nature with scientific innovation to deliver solutions that improve global health and wellness.

Recent filings

Filing Released Lang Actions
Decision Document / Order for Application - English.pdf
Regulatory Filings
2024-06-08 English
Notice.pdf
Delisting Announcement Classification · 95% confidence The document is titled 'NOTICE OF CHANGE IN CORPORATE STRUCTURE' and references a completed plan of arrangement under Canadian corporate law, involving acquisition and consolidation of shares. It details the transaction parties, approval dates, and the delisting of shares from exchanges. The document is short (3229 characters) and serves as an official announcement of a corporate transaction and subsequent delisting. It does not contain financial statements or detailed financial analysis but rather announces the completion of a merger/acquisition and the delisting of shares. Therefore, it fits best under the 'Delisting Announcement' category (DLST), as it explicitly states the shares will be delisted and the company will cease to be a reporting issuer. Confidence is high due to clear references to delisting and transaction completion.
2024-06-06 English
Material change report - English.pdf
Delisting Announcement Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Ceapro Inc. It announces a significant corporate event: the completion of a plan of arrangement (merger) where Aeterna Zentaris acquired all issued and outstanding shares of Ceapro, making Ceapro a wholly owned subsidiary. The document includes detailed information about the transaction, the exchange ratio, shareholder approvals, delisting of Ceapro shares from exchanges, and changes in board and management composition. It also references the delisting of Ceapro shares and cessation as a reporting issuer. The document is regulatory in nature, reporting a material corporate change, specifically a merger completion and delisting notice. This fits best under the category of Delisting Announcement (DLST) because it explicitly states the shares will be delisted and the company will cease to be a reporting issuer. Although it discusses the merger, the primary focus is on the material change report and delisting event. The document length (15,000 characters) and detailed content confirm it is not a mere announcement of a report but a substantive regulatory filing. Therefore, the most appropriate classification is DLST with high confidence.
2024-06-06 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a detailed announcement about the completion of a merger transaction between Aeterna Zentaris Inc. and Ceapro Inc. It includes information about the merger terms, the new board and executive leadership, operational strategy, and shareholder instructions related to share exchange and delisting of Ceapro shares. It also references prior filings and information circulars related to the transaction but does not itself contain financial statements or detailed financial performance data. The document is not a full annual or interim report, audit report, earnings release, or other financial report type. It is a corporate announcement about a merger completion and related corporate actions, which fits best under the category of M&A Activity (TAR). The length and detail confirm it is not a brief announcement or a regulatory filing fallback. Therefore, the appropriate classification is M&A Activity (TAR).
2024-06-03 English
News release - English.pdf
Regulatory Filings
2024-05-29 English
52-109FV2 - Certification of interim filings - CEO (E).PDF
Regulatory Filings
2024-05-29 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.